Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

NCT02152631

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
View all 231 locations
View Trial Details
Active, Not Recruiting

Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)

NCT04884282

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Cholet Cholet, France
  • GHR Mulhouse Sud Alsace - Hôpital Emile Muller Mulhouse, France
  • Nouvel Hôpital Civil - Hopitaux Universitaires de Strasbourg Strasbourg, France
View all 23 locations
View Trial Details
Active, Not Recruiting

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

NCT03808662

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +19 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

NCT07005336

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Chest Hospital Beijing, China
  • Binzhou Medical University Hospital Binzhou, China
  • Sichuan Cancer Hospital Chengdu, China
  • Chongqing University Three Gorges Hospital Chongqing, China
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

NCT06984588

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Anyang Tumour Hospital Anyang, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Bejing Chao-Yang Hospital, Capital Medical University Beijing, China
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, China
View all 64 locations
View Trial Details
Active, Not Recruiting

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

NCT05502237

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Innovative Clinical Research Institute Whittier, California, United States
  • George Washington Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Illinois Cancer Care Peoria, Illinois, United States
View all 186 locations
View Trial Details
Active, Not Recruiting

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

NCT03974022

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center Orange, California, United States
  • Innovative Clinical Research Institute, LLC Whittier, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 124 locations
View Trial Details

Related conditions